CDH2 and cancer: In the EMT, expression profiles of cadherin isoforms are typically switched from E-cadherin to N-cadherin in a process referred to as ‘cadherin switching’, which is associated with increased migratory and invasive behaviour of cancer cells (Wheelock et al., 2008).